Author response to: TaTME and the worse oncological outcome - new data demonstrates a difficult method
- PMID: 32940346
- DOI: 10.1002/bjs.11849
Author response to: TaTME and the worse oncological outcome - new data demonstrates a difficult method
Comment on
-
Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation.Br J Surg. 2020 Aug;107(9):1211-1220. doi: 10.1002/bjs.11525. Epub 2020 Apr 4. Br J Surg. 2020. PMID: 32246472 Free PMC article.
-
TaTME and the worse oncological outcome - new data demonstrates a difficult method.Br J Surg. 2020 Nov;107(12):e611. doi: 10.1002/bjs.11850. Epub 2020 Sep 16. Br J Surg. 2020. PMID: 32936942 No abstract available.
References
-
- van Oostendorp SE, Belgers HJ, Bootsma BT, Hol JC, Belt E, Bleeker W et al. Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation. Br J Surg 2020; 107: 1211-1220.
-
- Wasmuth HH, Faerden AE, Myklebust TA, Pfeffer F, Norderval S, Riis R et al. Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 2019; 107: 121-130.
-
- Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B et al. Transanal Total Mesorectal Excision for Rectal Cancer: Outcomes after 140 Patients. J Am Coll Surg 2015; 221: 415-423.
-
- Hol JC, van Oostendorp SE, Tuynman JB, Sietses C. Long-term oncological results after transanal total mesorectal excision for rectal carcinoma. Tech Coloproctol 2019; 23: 903-911.
-
- Roodbeen SX, Spinelli A, Bemelman WA, Di Candido F, Cardepont M, Denost Q et al. Local Recurrence After Transanal Total Mesorectal Excision for Rectal Cancer: A Multicenter Cohort Study. Ann Surg 2020; https://doi.org/10.1097/SLA.0000000000003757 [Epub ahead of print].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources